| Bionomics to expand tumour treatment trial - Ninemsn |
|
|
Ninemsn Bionomics is already trialling BNC105 for the treatment of renal cancer and mesothelioma. Bionomics said on that recent data from the renal cancer trial, where BNC105 is combined with another drug, supported progression of the trial. |